International Conference on Neurodegenerative Diseases and Therapeutics - (ICNDDT-26)


21st - 22nd November, 2026 | London, UK

Multi-format (In-person/Virtual)

Registration Options

Explore conference registration categories designed for every mode of participation.

Important Dates

Pre-registration Deadline

22nd October, 2026

Paper Submission Deadline

27th October, 2026

Last Date Of Registration

18th October, 2026

Date Of Conference

21st - 22nd November, 2026

Downloads

Call for Papers

The (ICNDDT-26) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Neurology, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Latest advancements in neurodegenerative therapies
  • Clinical trials for Alzheimer's disease treatments
  • Innovative approaches to Parkinson's disease management
  • Neuroinflammation and its role in neurodegeneration
  • Genetic factors in neurodegenerative diseases
  • Patient-centered care in neurodegenerative disorders
  • Neuroprotective strategies in aging populations
  • Impact of lifestyle on neurodegenerative diseases
  • Emerging biomarkers for early diagnosis
  • Role of neuroimaging in disease progression
  • Pharmacological interventions for cognitive decline
  • Ethical considerations in neurodegenerative research
  • Translational research in neurodegenerative diseases
  • Neurodegeneration and mental health comorbidities
  • Rehabilitation strategies for neurodegenerative patients
  • Role of nutrition in brain health
  • Technological innovations in disease monitoring
  • Patient advocacy and support networks
  • Future directions in neurodegenerative research
  • Global health perspectives on neurodegeneration

Peer Review Process

All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.

Registration Details

Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.